Consolidated Statement Of Cash Flows

D.Western Therapeutics Institute, Inc. - Filing #7272873

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,292,392,000 JPY
-583,081,000 JPY
Interest and dividends received
76,000 JPY
10,000 JPY
Interest paid
-5,197,000 JPY
-2,158,000 JPY
Income taxes paid
-1,605,000 JPY
-1,593,000 JPY
Net cash provided by (used in) operating activities
-1,299,118,000 JPY
-586,821,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-9,025,000 JPY
-12,026,000 JPY
Net cash provided by (used in) investing activities
-10,005,000 JPY
-15,254,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
0 JPY
Proceeds from issuance of bonds
660,000,000 JPY
JPY
Proceeds from long-term borrowings
226,000,000 JPY
166,000,000 JPY
Repayments of long-term borrowings
-9,524,000 JPY
-120,000,000 JPY
Redemption of bonds
-357,500,000 JPY
JPY
Net cash provided by (used in) financing activities
567,628,000 JPY
134,466,000 JPY
Effect of exchange rate change on cash and cash equivalents
266,000 JPY
205,000 JPY
Net increase (decrease) in cash and cash equivalents
-741,229,000 JPY
-467,404,000 JPY
Cash and cash equivalents
1,126,035,000 JPY
1,867,264,000 JPY
2,334,668,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.